How early diagnostics of lung cancer can lead to better survival rates with Chris Wood

Transformation in Trials

Transformation in Trials
How early diagnostics of lung cancer can lead to better survival rates with Chris Wood
Jul 02, 2025 Season 6 Episode 11
Sam Parnell & Ivanna Rosendal

Send us a text

Chris Wood discusses how early diagnostics of lung cancer through artificial intelligence and medical imaging can lead to better survival rates through early intervention. 

• Lung cancer takes more lives than breast, prostate and colon cancer combined, with approximately 70% of cases caught at late stages
• The National Lung Screening Trial showed that screening high-risk populations reduced mortality by 20%
• I-ELCAP research demonstrated an 80% twenty-year survival rate for early-stage cancers detected with CT scans and treated surgically
• Preventive healthcare is shifting from general advice to personalized screening protocols based on individual risk factors
• AI applications in medical imaging now assist with detection, characterization, and triage of disease
• Lung biopsies have a 22% complication rate, making non-invasive diagnostic methods particularly valuable
• AI-powered imaging can provide additional information to help clinicians decide whether to perform biopsies
• In clinical trials, AI imaging analysis could improve patient selection and help trials reach endpoints more efficiently 
• Medical imaging gives patients visual information about their bodies that can motivate healthier lifestyle changes
• The future of healthcare will likely focus on improving quality of life rather than simply extending lifespan

If you have a suggestion for a guest for our show, reach out to Sam Parnell or Ivanna Rosendal on LinkedIn. You can find more episodes on Apple Podcasts, Spotify, Google Podcasts or in any other player.


Support the show


________
Reach out to Ivanna Rosendal

Join the conversation on our LinkedIn page